Study of the ability of bifidobacteria of human origin to prevent and treat rotavirus infection using colonic cell and mouse models

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Gagnon, Mealanie ^a   Vimont, Allison ^a   Darveau, André ^a   Fliss, Ismaïl ^a   Jean, Julie ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM ADHERENCE; BIFIDOBACTERIUM; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM PSEUDOLONGUM; BIFIDOBACTERIUM THERMOPHILUM; CACO 2 CELL LINE; COLON CELL; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; DRUG MECHANISM; FEEDING BEHAVIOR; FEMALE; HT 29 CELL LINE; HUMAN; HUMAN CELL; HUMAN ROTAVIRUS STRAIN WA; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; INFECTION PREVENTION; INTESTINE CELL; MOUSE; MOUSE MODEL; NONHUMAN; ROTAVIRUS; ROTAVIRUS INFECTION; SUCKLING ANIMAL; VIRUS ATTACHMENT; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; BLOOD; CACO-2 CELL LINE; COLON; DISEASE MODEL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; HT-29 CELL LINE; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; ROTAVIRUS INFECTIONS; VIROLOGY; VIRUS ENTRY;

ANIMALS; BIFIDOBACTERIUM; CACO-2 CELLS; COLON; DIARRHEA; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HT29 CELLS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICE; PROBIOTICS; ROTAVIRUS; ROTAVIRUS INFECTIONS; VIRUS INTERNALIZATION;

EID: 84991466894     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0164512     Document Type: Article

References (78)

1. Bilcke J, Van Damme P, Van Ranst M, Hens N, Aerts M, Beutels P. Estimating the incidence of symptomatic rotavirus infections: A systematic review and meta-analysis. PLoS ONE. 2009;4(6):e6060. doi: 10.1371/journal.pone.0006060 PMID: 19557133
2. Lanata CF, Fischer-Walker CL, Olascoaga AC, Torres CX, Aryee MJ, Black RE. Global causes of diarrheal disease mortality in children < 5 years of age: A systematic review. PLoS ONE. 2013;8(9):e72788. doi: 10.1371/journal.pone.0072788 PMID: 24023773
3. World Health Organisation. Rotavirus vaccines. WHO position paper-January 2013. http://www.who. int/wer/2013/wer8805.pdf. Weekly Epidemiological Record. 2013; 88th year (5): 49-64.
4. Estes M, Greenberg HB. Rotaviruses. In: Knipe D, Howley P, editors. Fields Virology. Volume 1. 6th ed. Philadelphia, PA, USA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2013. p. 1347-401.
5. Graham DY, Dufour GR, Estes M. Minimal infective dose of rotavirus. Archives of Virology. 1987;92(3-4):261-71. doi: 10.1007/BF01317483 PMID: 3028333
6. Ansari SA, Sattar SA, Springthorpe VS, Wells GA, Tostowaryk W. Rotavirus survival on human hands and transfer of infectious virus to animate and nonporous inanimate surfaces. Journal of Clinical Microbiology. 1988;26(8):1513-8. PMID: 2844846
7. Sattar SA, Lloyd-Evans N, Springthorpe VS, Nair RC. Institutional outbreaks of rotavirus diarrhoea: Potential role of fomites and environmental surfaces as vehicles for virus transmission. Epidemiology & Infection. 1986;96(02):277-89. doi: 10.1017/S0022172400066055 PMID: 3701042
8. King AMQ, Adams MJ, Lefkowitz EJ. Family: Reoviridae. In: King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ, editors. International Committee on Taxonomy of Viruses: Ninth Report of the International Committee on Taxonomy of Viruses, International Union of Microbiological Societies. Volume 9. San Diego, CA, USA: Elsevier; 2011. p. 541-637.
9. Arias CF, Silva-Ayala D, López S. Rotavirus entry: A deep journey into the cell with several exits. Journal of Virology. 2015;89(2):890-3. doi: 10.1128/JVI.01787-14 PMID: 25378490
10. Gavi. Rotavirus vaccine support 2015 [23 september 2015]. Available from: http://www.gavi.org/support/nvs/rotavirus/.
11. Clarke E, Desselberger U. Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings. Mucosal Immunol. 2015;8(1):1-17. doi: 10.1038/mi. 2014.114 PMID: 25465100
12. Atchison CJ, Stowe J, Andrews N, Collins S, Allen DJ, Nawaz S, et al. Rapid declines in age group-specific rotavirus infection and acute gastroenteritis among vaccinated and unvaccinated individuals within 1 year of rotavirus vaccine introduction in England and Wales. Journal of Infectious Diseases. 2016;213(2):243-9. doi: 10.1093/infdis/jiv398 PMID: 26232438
13. Robinson CM, Pfeiffer JK. Viruses and the microbiota. Annual review of virology. 2014;1:55-69. doi: 10.1146/annurev-virology-031413-085550. PMC4373533. PMID: 25821837
14. Pfeiffer JK, Virgin HW. Transkingdom control of viral infection and immunity in the mammalian intestine. Science. 2016;351(6270):aad5872. doi: 10.1126/science.aad5872 PMID: 26816384
15. Jones MK, Watanabe M, Zhu S, Graves CL, Keyes LR, Grau KR, et al. Enteric bacteria promote human and mouse norovirus infection of B cells. Science. 2014;346(6210):755-9. doi: 10.1126/science.1257147 PMID: 25378626
16. Uchiyama R, Chassaing B, Zhang B, Gewirtz AT. Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity. Journal of Infectious Diseases. 2014. doi: 10.1093/infdis/jiu037 PMID: 24436449
17. Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Systematic Reviews 2010; (11:). doi: 10.1002/14651858. CD003048.pub3
18. Mrukowicz J, Szajewska H, Vesikari T. Options for the prevention of rotavirus disease other than vaccination. Journal of Pediatric Gastroenterology and Nutrition. 2008;46:S32-S7. doi: 10.1097/MPG. 0b013e31816f79b0. 00005176-200805002-00005. PMID: 18460970
19. Food and Agricultural Organization of the United Nations, World Health Organization. Joint FAO/WHO working group report on drafting guidelines for the evaluation of probiotics in food. Food and Agricultural Organization of the United Nations [online]. ftp://ftpfaoorg/es/esn/food/wgreport2pdf2002.
20. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology. 2014;11(8):506-14. doi: 10.1038/nrgastro.2014.66 PMID: 24912386
21. Gagnon M, Zihler A, Chassard C, Lacroix C. Ecology of probiotics and enteric protection. In: Malago JJ K J, Marinsek-Logar R., editor. Probiotic Bacteria and Enteric Infections-Cytoprotection by probiotic bacteria. Volume 1. New York, NY, USA: Springer Science+Business Media B. V.; 2011. p. 65-85. doi: 10.1039/c5fo01581b
22. Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in intestinal health and disease. Nature Reviews Gastroenterology & Hepatology. 2010;7(9):503-14. doi: 10.1038/nrgastro. 2010.117 PMID: 20664519
23. Freitas M, Tavan E, Cayuela C, Diop L, Sapin C, Trugnan G. Host-pathogens cross-talk. Indigenous bacteria and probiotics also play the game. Biology of the Cell. 2003;95(8):503-6. PMID: 14630386
24. Haschke F, Wang W, Ping G, Varavithya W, Podhipak A, Rochat F, et al. Clinical trials prove the safety and efficacy of the probiotic strain Bifidobacterium Bb12 in follow-up formula and growing-up milks. Monatsschr Kinderheilkd. 1998;146(1):S26-S30. doi: 10.1007/PL00014763
25. Szajewska H, Skôrka A, Ruszczyński M, Gieruszczak-Biaoek D. Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children-updated analysis of randomised controlled trials. Alimentary Pharmacology & Therapeutics. 2013;38(5):467-76. doi: 10.1111/apt.12403 PMID: 23841880
26. Guandalini S, Pensabene L, Zikri MA, Dias JA, Casali LG, Hoekstra H, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. Journal of Pediatric Gastroenterology and Nutrition. 2000;30(1):54-60. PMID: 10630440
27. Sarker SA, Sultana S, Fuchs GJ, Alam NH, Azim T, Brüssow H, et al. Lactobacillus paracasei strain ST11 has no effect on rotavirus but ameliorates the outcome of nonrotavirus diarrhea in children from Bangladesh. Pediatrics. 2005;116(2):e221-e8. doi: 10.1542/peds.2004-2334 PMID: 15995003
28. Saavedra JM, Bauman NA, Perman JA, Yolken RH, Saavedra JM, Bauman NA, et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. The Lancet. 1994;344(8929):1046-9. doi: 10.1016/S0140-6736 (94) 91708-6 PMID: 7934445
29. Kandasamy S, Vlasova AN, Fischer D, Kumar A, Chattha KS, Rauf A, et al. Differential effects of Escherichia coli Nissle and Lactobacillus rhamnosus strain GG on human rotavirus binding, infection, and B cell immunity. The Journal of Immunology. 2016. doi: 10.4049/jimmunol.1501705 PMID: 26800875
30. Grandy G, Medina M, Soria R, Teran C, Araya M. Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children. BMC Infectious Diseases. 2010;10(1):253. doi: 10.1186/1471-2334-10-253 PMID: 20735858
31. Touré R, Kheadr E, Lacroix C, Moroni O, Fliss I. Production of antibacterial substances by bifidobacterial isolates from infant stool active against Listeria monocytogenes. Journal of Applied Microbiology. 2003;95(5):1058-69. doi: 10.1046/j.1365-2672.2003.02085.x PMID: 14633035
32. von Ah U, Mozzetti V, Lacroix C, Kheadr EE, Fliss I, Meile L. Classification of a moderately oxygen-tolerant isolate from baby faeces as Bifidobacterium thermophilum. BMC microbiology. 2007;7(1):79. doi: 10.1186/1471-2180-7-79 PMID: 17711586
33. Wold AE, Adlerberth I. Breast feeding and the intestinal microflora of the infant-implications for protection against infectious diseases. In: Koletzko B, Michaelsen K, Hernell O, editors. Short and Long Term Effects of Breast Feeding on Child Health. Advances in Experimental Medicine and Biology. 478: Springer US; 2002. p. 77-93. doi: 10.1007/0-306-46830-1-7 PMID: 11065062
34. Di Gioia D, Aloisio I, Mazzola G, Biavati B. Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants. Applied Microbiology and Biotechnology. 2014;98(2):563-77. doi: 10.1007/s00253-013-5405-9 PMID: 24287935
35. Bottacini F, Ventura M, van Sinderen D, Motherway MOC. Diversity, ecology and intestinal function of bifidobacteria. Microbial Cell Factories. 2014;13(Suppl 1):S4. doi: 10.1186/1475-2859-13-S1-S4 PMID: 25186128
36. Kheadr E, Bernoussi N, Lacroix C, Fliss I. Comparison of the sensitivity of commercial strains and infant isolates of bifidobacteria to antibiotics and bacteriocins. International Dairy Journal. 2004;14(12):1041-53. doi: 10.1016/j.idairyj.2004.04.010
37. von Ah U. Identification of Bifidobacterium thermophilum RBL67 isolated from baby faeces and partial purification of its bacteriocin-PhD thesis. Diss Nr 16927. Zürich, Switzerland2006.
38. Zihler A, Blay G, Chassard C, Braegger C, Lacroix C. Bifidobacterium thermophilum RBL67 inhibits Salmonella enterica Serovar Typhimurium in an in vitro intestinal fermentation model. Journal of Food & Nutritional Disorders. 2014; S1-003. doi: 10.4172/2324-9323. S1-003
39. Zihler A, Gagnon M, Chassard C, Lacroix C. Protective effect of probiotics on Salmonella infectivity assessed with combined in vitro gut fermentation-cellular models. BMC Microbiology. 2011;11(1):1-13. doi: 10.1186/1471-2180-11-264 PMID: 22171685
40. Jans C, Lacroix C, Follador R, Stevens MJ. Complete genome sequence of the probiotic Bifidobacterium thermophilum strain RBL67. Genome announcements. 2013;1(3):e00191-13. doi: 10.1128/genomeA.00191-13 PMID: 23640377
41. Gagnon M, Kheadr EE, Le Blay G, Fliss I. In vitro inhibition of Escherichia coli O157:H7 by bifidobacterial strains of human origin. International Journal of Food Microbiology. 2004;92(1):69-78. doi: 10. 1016/j.ijfoodmicro.2003.07.010 PMID: 15033269
42. Beerens H. An elective and selective isolation medium for Bifidobacterium spp. Letters in Applied Microbiology. 1990;11(3):155-7. doi: 10.1111/j.1472-765X.1990.tb00148.x
43. Jean J, Blais B, Darveau A. Rapid detection of human rotavirus using colorimetric nucleic acid sequence-based amplification (NASBA)-enzyme-linked immunosorbent assay in sewage treatment effluent. FEMS microbiology letters. 2002;210(1):143-7. PMID: 12023091
44. Ramia S, Sattar SA. Simian rotavirus SA-11 plaque formation in the presence of trypsin. Journal of Clinical Microbiology. 1979;10(5):609-14. PMID: 94597
45. Canadian Council on Animal Care. Guide to the Care and Use of Experimental Animals. 2nd ed. Olfert ED C B, McWilliam AA, editor. Ottawa, ON, Canada: CCAC Press; 1993. 1-232 p.
46. Gagnon M, Kheadr EE, Dabour N, Richard D, Fliss I. Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB/c mice. International Journal of Food Microbiology. 2006;111(1):26-33. doi: 10.1016/j.ijfoodmicro.2006.04.041 PMID: 16822570
47. Shu Q, Gill HS. A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity of Escherichia coli O157:H7 infection in mice. Medical microbiology and immunology. 2001;189(3):147-52. PMID: 11388612
48. Crociani J, Grill JP, Huppert M, Ballongue J. Adhesion of different bifidobacteria strains to human enterocyte-like Caco-2 cells and comparison with in vivo study. Letters in Applied Microbiology. 1995;21(3):146-8. doi: 10.1111/j.1472-765X.1995.tb01027.x PMID: 7576496
49. Boshuizen JA, Reimerink JHJ, Korteland-van Male AM, van Ham VJJ, Koopmans MPG, Büller HA, et al. Changes in small intestinal homeostasis, morphology, and gene expression during rotavirus infection of infant mice. Journal of Virology. 2003;77(24):13005-16. doi: 10.1128/jvi.77.24.13005-13016.2003 PMID: 14645557
50. Colbère-Garapin F, Martin-Latil S, Blondel B, Mousson L, Pelletier I, Autret A, et al. Prevention and treatment of enteric viral infections: possible benefits of probiotic bacteria. Microbes and Infection. 2007;9(14):1623-31. doi: 10.1016/j.micinf.2007.09.016 PMID: 18023231
51. Picard C, Fioramonti J, Francois A, Robinson T, Neant F, Matuchansky C. Review article: Bifidobacteria as probiotic agents-physiological effects and clinical benefits. Alimentary Pharmacology & Therapeutics. 2005;22(6):495-512. doi: 10.1111/j.1365-2036.2005.02615.x PMID: 16167966
52. Russell DA, Ross RP, Fitzgerald GF, Stanton C. Metabolic activities and probiotic potential of bifidobacteria. International Journal of Food Microbiology. 2011;149(1):88-105. doi: 10.1016/j.ijfoodmicro. 2011.06.003 PMID: 21763022
53. Gagnon M, Zihler Berner A, Chervet N, Chassard C, Lacroix C. Comparison of the Caco-2, HT-29 and the mucus-secreting HT29-MTX intestinal cell models to investigate Salmonella adhesion and invasion. Journal of Microbiological Methods. 2013;94(3):274-9. doi: 10.1016/j.mimet.2013.06.027 PMID: 23835135
54. Serafini F, Strati F, Ruas-Madiedo P, Turroni F, Foroni E, Duranti S, et al. Evaluation of adhesion properties and antibacterial activities of the infant gut commensal Bifidobacterium bifidum PRL2010. Anaerobe. 2013;21:9-17. doi: 10.1016/j.anaerobe.2013.03.003 PMID: 23523946
55. Gopal PK, Prasad J, Smart J, Gill HS. In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. International Journal of Food Microbiology. 2001;67(3):207-16. doi: 10.1016/S0168-1605 (01) 00440-8 PMID: 11518430
56. Candela M, Biagi E, Centanni M, Turroni S, Vici M, Musiani F, et al. Bifidobacterial enolase, a cell surface receptor for human plasminogen involved in the interaction with the host. Microbiology. 2009;155(10):3294-303. doi: 10.1099/mic.0.028795-0 PMID: 19574304
57. González-Rodríguez I, Sánchez B, Ruiz L, Turroni F, Ventura M, Ruas-Madiedo P, et al. Role of extracellular transaldolase from Bifidobacterium bifidum in mucin adhesion and aggregation. Applied and Environmental Microbiology. 2012;78(11):3992-8. doi: 10.1128/aem.08024-11 PMID: 22447584
58. Moreno Muñoz JA, Chenoll E, Casinos B, Bataller E, Ramón D, Genovés S, et al. Novel probiotic Bifidobacterium longum subsp. infantis CECT 7210 strain active against rotavirus infections. Applied and Environmental Microbiology. 2011;77(24):8775-83. doi: 10.1128/aem.05548-11 PMID: 22003027
59. Lee DK, Park JE, Kim MJ, Seo JG, Lee JH, Ha NJ. Probiotic bacteria, B. longum and L. acidophilus inhibit infection by rotavirus in vitro and decrease the duration of diarrhea in pediatric patients. Clinics and Research in Hepatology and Gastroenterology. 2015;39(2):237-44. doi: 10.1016/j.clinre.2014. 09.006 PMID: 25459995
60. Offit PA, Clark HF, Kornstein MJ, Plotkin SA. A murine model for oral infection with a primate rotavirus (simian SA11). Journal of Virology. 1984;51(1):233-6. PMID: 6328042
61. Burns JW, Krishnaney AA, Vo PT, Rouse RV, Anderson LJ, Greenberg HB. Analyses of homologous rotavirus infection in the mouse model. Virology. 1995;207(1):143-53. doi: 10.1006/viro.1995.1060 PMID: 7871723
62. Tannock G, Munro K, Harmsen H, Welling G, Smart J, Gopal P. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Applied and environmental microbiology. 2000;66(6):2578-88. doi: 10.1128/AEM.66.6.2578-2588. 2000PMID: 10831441
63. Franco MA, Greenberg HB. Immunity to rotavirus in T cell deficient mice. Virology. 1997;238(2):169-79. doi: 10.1006/viro.1997.8843 PMID: 9400590
64. Baumgarth N, Tung J, Herzenberg L. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin Immun. 2005;26(4):347-62. doi: 10.1007/s00281-004-0182-2 PMID: 15633017
65. Liu F, Li G, Wen K, Wu S, Zhang Y, Bui T, et al. Lactobacillus rhamnosus GG on rotavirus-induced injury of ileal epithelium in gnotobiotic pigs. Journal of Pediatric Gastroenterology and Nutrition. 2013;57(6):750-8. doi: 10.1097/MPG.0b013e3182a356e1 PMID: 24280990
66. Zhang W, Azevedo MS, Gonzalez AM, Saif LJ, Van Nguyen T, Wen K, et al. Influence of probiotic Lactobacilli colonization on neonatal B cell responses in a gnotobiotic pig model of human rotavirus infection and disease. Veterinary Immunology and Immunopathology. 2008;122(1):175-81. doi: 10.1016/j. vetimm.2007.10.003 PMID: 18023882
67. Vlasova AN, Chattha KS, Kandasamy S, Liu Z, Esseili M, Shao L, et al. Lactobacilli and bifidobacteria promote immune homeostasis by modulating innate immune responses to human rotavirus in neonatal gnotobiotic pigs. PLoS ONE. 2013;8(10):e76962. doi: 10.1371/journal.pone.0076962 PMID: 24098572
68. O'Toole PW, Cooney JC. Probiotic bacteria influence the composition and function of the intestinal microbiota. Interdisciplinary Perspectives on Infectious Diseases. 2008. doi: 10.1155/2008/175285
69. Franco MA, Angel J, Greenberg HB. Immunity and correlates of protection for rotavirus vaccines. Vaccine. 2006;24(15):2718-31. doi: 10.1016/j.vaccine.2005.12.048 PMID: 16446014
70. Qiao H, Duffy LC, Griffiths E, Dryja D, Leavens A, Rossman J, et al. Immune responses in rhesus rotavirus-challenged BALB/c mice treated with bifidobacteria and prebiotic supplements. Pediatric Research. 2002;51(6):750-5. doi: 10.1203/00006450-200206000-00015 PMID: 12032272
71. Mohan R, Koebnick C, Schildt J, Mueller M, Radke M, Blaut M. Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatric Research. 2008;64(4):418-22. doi: 10.1203/PDR.0b013e318181b7fa PMID: 18552710
72. Fukushima Y, Kawata Y, Hara H, Terada A, Mitsuoka T. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. International Journal of Food Microbiology. 1998;42(1-2):39-44. doi: 10.1016/S0168-1605 (98) 00056-7 PMID: 9706796
73. Yasui H, Kiyoshima J, Ushijima H. Passive protection against rotavirus-induced diarrhea of mouse pups born to and nursed by dams fed Bifidobacterium breve YIT4064. The Journal of Infectious Diseases. 1995;172(2):403-9. doi: 10.2307/30135785 PMID: 7622883
74. Ashraf R, Shah NP. Immune system stimulation by probiotic microorganisms. Critical Reviews in Food Science and Nutrition. 2013;54(7):938-56. doi: 10.1080/10408398.2011.619671 PMID: 24499072
75. O'Neal CM, Harriman GR, Conner ME. Protection of the villus epithelial cells of the small intestine from rotavirus infection does not require immunoglobulin A. Journal of Virology. 2000;74(9):4102-9. doi: 10.1128/jvi.74.9.4102-4109.2000 PMID: 10756022
76. Istrate C, Hinkula J, Hammarström L, Svensson L. Individuals with selective IgA deficiency resolve rotavirus disease and develop higher antibody titers (IgG, IgG1) than IgA competent individuals. Journal of Medical Virology. 2008;80(3):531-5. doi: 10.1002/jmv. 21101 PMID: 18205219
77. Cerutti A, Rescigno M. The biology of intestinal immunoglobulin A responses. Immunity. 2008;28(6):740-50. doi: 10.1016/j.immuni.2008.05.001 PMID: 18549797
78. Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiology Reviews. 2004;28(4):405-40. doi: 10.1016/j.femsre.2004.01.003 PMID: 15374659